Jaspal Sekhon

Jaspal is a partner in the corporate team, specialising in corporate finance, transactional and advisory work for UK and international clients.

Download Card

Jaspal has experience of capital markets work including IPOs and secondary fundraisings (on the Main Market and AIM) as well as public and private mergers and acquisitions, joint ventures and corporate reorganisations. He also has extensive experience of advising on equity fundraisings and investments (particularly for growth companies).

Jaspal has varied experience across a number of sectors including natural resources, real estate, technology and financial services.

Experience
Advising Main Market company ADES International Holding plc on its US$516 million recommended cash takeover by Innovative Energy Holding Ltd
Advising a global maritime group on the sale of a controlling stake in the group for US$448 million
Advising European medical cannabis and wellness company, EMMAC Life Sciences, on its acquisition of Portuguese genetics and cultivation company, Terra Verde LDA
Advising AIM-listed Minds + Machines Group Limited (MMX) on its acquisition of ICM Registry LLC, the owner and operator of four high value niche internet top-level domain names, for US$40 million and the subsequent sale by MMX of the majority of its assets to GoDaddy Inc, for US$120 million
Advising Great Bear Petroleum Operating LLC on the UK aspects of the sale of its two wholly-owned subsidiaries, Great Bear Petroleum Ventures I LLC and Great Bear Petroleum Ventures II LLC, to AIM-listed Pantheon Resources Plc for US$49 million
Advising AIM-listed UK Oil & Gas Plc on various transactions including its re-admission to AIM following its change from an investment company to an operating company and several fundraisings
Advising AIM-listed SigmaRoc Plc on various acquisitions including its £35.5m acquisition of Johnston Quarry Group and its acquisition of specialist concrete producer, Poundfield Products (Group) Limited, for £10.3 million
Advising Genflow Biosciences plc (LON: GENF), the first pure-play longevity biotechnology firm to list in Europe, on a £3.7 million oversubscribed placing and the company’s admission to the standard segment of the main market of the London Stock Exchange
Affiliations
Member of the Law Society
Member of the Legal Expert Group of the Quoted Companies Alliance

Jaspal Sekhon is recommended for M&A – Smaller Deals up to £50m

The Legal 500 2023 l Leading Firm

Jaspal Sekhon is recommended for Equity Capital Markets – Small-Mid Cap

The Legal 500 2022 | Leading Firm

Jaspal Sekhon's Expertise

Corporate

Delivering a high-quality combination of technical expertise, commercial acumen and excellent client service, our clients value the quality of our people, our market knowledge and our...

Property and construction law

From planning and construction to buying, selling and managing investments, our award-winning specialist lawyers can help with all aspects of property legal services. Our large practi...

Technology and IT

Technology law is central to any large-scale business transaction or dispute. Whether you are a technology organisation, or an organisation reliant on technology, as your organisation...

Jaspal Sekhon

Experience

Affiliations